Kilitch Drugs (India) Limited

NSE: KILITCH · Healthcare

Overview

Kilitch Drugs (India) Limited Share Price & Analysis

₹173.7▼ -2.33%Updated 5 Jun 2026, 05:02 pm IST
LTP
₹173.7
-2.33%
Open
₹—
High
₹180.75
Low
₹172
Close
₹173.7
52W High
₹250
52W Low
₹117
Volume
37K
Lot Size
1
Sector
Healthcare
Market Cap
₹624 Cr
Face Value
₹10
Small Cap

Price Chart

Fundamentals

P/E
20.7
Sector P/E
48.9
P/B
2.17
EPS
₹7.45
ROE
12.5%
ROCE
14.4%
D/E Ratio
0.32
Div Yield
0%
Book Value
₹80
+

Strengths

  • ✓Attractively valued vs sector (P/E 20.7x vs industry 48.9x)
  • ✓Low debt relative to equity (D/E 0.3x)

Peer Comparison

CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
SUNPHARMA
Sun Pharmaceutical Industries Limited
₹1,783
₹4.3L Cr34.45.121620.50.07
DIVISLAB
Divi's Laboratories Limited
₹6,616
₹1.7L Cr66.110.4816.5220.01
TORNTPHARM
Torrent Pharmaceuticals Limited
₹4,416
₹1.5L Cr66.417.8127.615.40.33
APOLLOHOSP
Apollo Hospitals Enterprise Limited
₹8,315
₹1.2L Cr59.512.6222.117.90.88
CIPLA
Cipla Limited
₹1,402
₹1.1L Cr27.33.2912.416.60.01
ZYDUSLIFE
Zydus Lifesciences Limited
₹1,091
₹1.1L Cr204.0521.221.20.38
DRREDDY
Dr. Reddy's Laboratories Limited
₹1,283
₹1.1L Cr25.42.8311.813.60.16

Showing 7 peers in the same sector · Sorted by market cap

Corporate Events

To consider and approve the financial results for the period ended March 31, 2026

Results14 May 2026

Bonus 1:1

Bonus23 Mar 2026

Rights 2:23 @ Premium Rs 347/-

Rights14 Jul 2025

Annual General Meeting

AGM18 Sept 2024

Annual General Meeting

AGM20 Sept 2023

Latest News

All news →

Kilitch Drugs shows strong earnings but underlying issues persist

*Kilitch Drugs (India)'s healthy earnings may be misleading due to one-time gains and declining core margins.* Revenue grew by **12% YoY**, but operating profit growth was only **4%**, indicating cost pressures. Debt levels remain elevated at **₹320 crore**, raising concerns over sustainability. 📊 *STOCKS:* KILITCH | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Earnings

simplywall.st27 May
Medium Impact

Financials

Quarterly Results

MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Revenue
₹54 Cr
▲10.2%
₹49 Cr
▲14.0%
₹43 Cr
▼29.5%
₹61 Cr
▲8.9%
₹56 Cr
▲19.1%
₹47 Cr
▲42.4%
₹33 Cr
▼26.4%
₹44.82 Cr
Op. Profit
₹6 Cr
▲20.0%
₹5 Cr
▲66.7%
₹3 Cr
▼80.0%
₹15 Cr
▲66.7%
₹9 Cr
▲50.0%
₹6 Cr
▲200.0%
₹2 Cr
▼71.8%
₹7.08 Cr
OPM
11.0%
▲10.0%
10.0%
▲25.0%
8.0%
▼66.7%
24.0%
▲50.0%
16.0%
▲23.1%
13.0%
▲160.0%
5.0%
▼68.4%
15.8%
Net Profit
₹4 Cr
▼50.0%
₹8 Cr
▲300.0%
₹2 Cr
▼80.0%
₹10 Cr
▲66.7%
₹6 Cr
▼33.3%
₹9 Cr
₹0 Cr
▼100.0%
₹3.68 Cr
EPS (₹)
1.27
▼45.7%
2.34
▲169.0%
0.87
▼70.7%
2.97
▲74.7%
1.7
▼30.9%
2.46
▲547.4%
0.38
▼63.1%
1.03

Values in ₹ Cr · Source: Screener.in

Annual Profit & Loss

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Revenue
₹235 Cr
▲18.7%
₹198 Cr
▲28.6%
₹154 Cr
▲10.0%
₹140 Cr
▲22.8%
₹114 Cr
▲67.6%
₹68 Cr
▲28.3%
₹53 Cr
▼35.4%
₹82 Cr
▲60.8%
₹51 Cr
▲88.9%
₹27 Cr
Expenses
₹199 Cr
▲19.2%
₹167 Cr
▲28.5%
₹130 Cr
▲6.6%
₹122 Cr
▲17.3%
₹104 Cr
▲65.1%
₹63 Cr
▲18.9%
₹53 Cr
▼29.3%
₹75 Cr
▲66.7%
₹45 Cr
▲60.7%
₹28 Cr
Op. Profit
₹37 Cr
▲15.6%
₹32 Cr
▲33.3%
₹24 Cr
▲33.3%
₹18 Cr
▲80.0%
₹10 Cr
▲100.0%
₹5 Cr
₹0 Cr
▼100.0%
₹7 Cr
▲16.7%
₹6 Cr
▲700.0%
₹-1 Cr
OPM
16.0%
▲0.0%
16.0%
▲0.0%
16.0%
▲23.1%
13.0%
▲44.4%
9.0%
▲12.5%
8.0%
▲700.0%
1.0%
▼88.9%
9.0%
▼18.2%
11.0%
▲650.0%
-2.0%
Other Income
₹11 Cr
▲0.0%
₹11 Cr
▲175.0%
₹4 Cr
▲33.3%
₹3 Cr
▲0.0%
₹3 Cr
▲0.0%
₹3 Cr
▼25.0%
₹4 Cr
▲0.0%
₹4 Cr
▲33.3%
₹3 Cr
▲200.0%
₹1 Cr
Interest
₹6 Cr
▲20.0%
₹5 Cr
▼16.7%
₹6 Cr
▲20.0%
₹5 Cr
▲400.0%
₹1 Cr
▲0.0%
₹1 Cr
▲0.0%
₹1 Cr
▲0.0%
₹1 Cr
₹0 Cr
₹0 Cr
Depreciation
₹4 Cr
▲33.3%
₹3 Cr
▲0.0%
₹3 Cr
▼25.0%
₹4 Cr
▲100.0%
₹2 Cr
▲0.0%
₹2 Cr
▲0.0%
₹2 Cr
▲0.0%
₹2 Cr
▲0.0%
₹2 Cr
▼80.0%
₹10 Cr
PBT
₹39 Cr
▲14.7%
₹34 Cr
▲78.9%
₹19 Cr
▲58.3%
₹12 Cr
▲20.0%
₹10 Cr
▲100.0%
₹5 Cr
▲150.0%
₹2 Cr
▼77.8%
₹9 Cr
▲50.0%
₹6 Cr
▲166.7%
₹-9 Cr
Tax %
24.0%
▼14.3%
28.0%
▼6.7%
30.0%
▼3.2%
31.0%
▼11.4%
35.0%
▲29.6%
27.0%
▼43.8%
48.0%
▼12.7%
55.0%
▲243.8%
16.0%
▲420.0%
-5.0%
Net Profit
₹30 Cr
▲20.0%
₹25 Cr
▲78.6%
₹14 Cr
▲75.0%
₹8 Cr
▲33.3%
₹6 Cr
▲50.0%
₹4 Cr
▲300.0%
₹1 Cr
▼75.0%
₹4 Cr
▼20.0%
₹5 Cr
▲155.6%
₹-9 Cr
EPS (₹)
8.63
▲13.1%
7.63
▲83.0%
4.17
▲35.4%
3.08
▲41.9%
2.17
▲99.1%
1.09
▲336.0%
0.25
▼78.3%
1.15
▼33.1%
1.72
▲155.7%
-3.09
Div Payout
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
▼100.0%
20.0%
▲53.8%
13.0%
0.0%

Values in ₹ Cr · Source: Screener.in

Balance Sheet

ItemSep 2025Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Liabilities
Equity Capital
₹17 Cr
▲6.3%
₹16 Cr
▲0.0%
₹16 Cr
▲0.0%
₹16 Cr
▲0.0%
₹16 Cr
▲6.7%
₹15 Cr
▲0.0%
₹15 Cr
▲0.0%
₹15 Cr
▲7.1%
₹14 Cr
▲7.7%
₹13 Cr
Reserves
₹248 Cr
▲33.3%
₹186 Cr
▲16.3%
₹160 Cr
▲17.6%
₹136 Cr
▲9.7%
₹124 Cr
▲10.7%
₹112 Cr
▲8.7%
₹103 Cr
▼2.8%
₹106 Cr
▲8.2%
₹98 Cr
▲11.4%
₹88 Cr
Borrowings
₹84 Cr
▲71.4%
₹49 Cr
▲53.1%
₹32 Cr
▲45.5%
₹22 Cr
▲10.0%
₹20 Cr
▲33.3%
₹15 Cr
▲15.4%
₹13 Cr
▲44.4%
₹9 Cr
▲800.0%
₹1 Cr
▲0.0%
₹1 Cr
Other Liabilities
₹49 Cr
▼19.7%
₹61 Cr
▲90.6%
₹32 Cr
▼30.4%
₹46 Cr
▼8.0%
₹50 Cr
▼18.0%
₹61 Cr
▲408.3%
₹12 Cr
▼7.7%
₹13 Cr
▼13.3%
₹15 Cr
▲36.4%
₹11 Cr
Total Liabilities
₹399 Cr
▲27.5%
₹313 Cr
▲30.4%
₹240 Cr
▲9.1%
₹220 Cr
▲4.8%
₹210 Cr
▲3.4%
₹203 Cr
▲42.0%
₹143 Cr
▼0.7%
₹144 Cr
▲12.5%
₹128 Cr
▲13.3%
₹113 Cr
Assets
Fixed Assets
₹64 Cr
▲0.0%
₹64 Cr
▲3.2%
₹62 Cr
▼3.1%
₹64 Cr
▼1.5%
₹65 Cr
▲116.7%
₹30 Cr
▼6.3%
₹32 Cr
▲0.0%
₹32 Cr
▼3.0%
₹33 Cr
▲0.0%
₹33 Cr
CWIP
₹98 Cr
▲108.5%
₹47 Cr
▲683.3%
₹6 Cr
▲50.0%
₹4 Cr
▲33.3%
₹3 Cr
▼95.4%
₹65 Cr
▲116.7%
₹30 Cr
▲50.0%
₹20 Cr
▲566.7%
₹3 Cr
▲200.0%
₹1 Cr
Investments
₹77 Cr
▲6.9%
₹72 Cr
▲0.0%
₹72 Cr
▲16.1%
₹62 Cr
▼12.7%
₹71 Cr
▲18.3%
₹60 Cr
▲15.4%
₹52 Cr
▼1.9%
₹53 Cr
▼5.4%
₹56 Cr
▲5.7%
₹53 Cr
Other Assets
₹160 Cr
▲24.0%
₹129 Cr
▲29.0%
₹100 Cr
▲11.1%
₹90 Cr
▲26.8%
₹71 Cr
▲51.1%
₹47 Cr
▲56.7%
₹30 Cr
▼21.1%
₹38 Cr
▲8.6%
₹35 Cr
▲34.6%
₹26 Cr
Total Assets
₹399 Cr
▲27.5%
₹313 Cr
▲30.4%
₹240 Cr
▲9.1%
₹220 Cr
▲4.8%
₹210 Cr
▲3.4%
₹203 Cr
▲42.0%
₹143 Cr
▼0.7%
₹144 Cr
▲12.5%
₹128 Cr
▲13.3%
₹113 Cr

Values in ₹ Cr · Source: Screener.in

Cash Flow Statement

ItemMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Operating CF
₹18 Cr
▲1000.0%
₹-2 Cr
▼166.7%
₹3 Cr
▼50.0%
₹6 Cr
▼87.0%
₹46 Cr
▲1050.0%
₹4 Cr
₹0 Cr
▼100.0%
₹1 Cr
▲0.0%
₹1 Cr
▼94.1%
₹17 Cr
Investing CF
₹-40 Cr
▼400.0%
₹-8 Cr
▼200.0%
₹8 Cr
▲153.3%
₹-15 Cr
▲60.5%
₹-38 Cr
▼280.0%
₹-10 Cr
▲28.6%
₹-14 Cr
▼250.0%
₹-4 Cr
▼100.0%
₹-2 Cr
▲90.0%
₹-20 Cr
Financing CF
₹13 Cr
▲44.4%
₹9 Cr
▲1000.0%
₹-1 Cr
▼114.3%
₹7 Cr
▲250.0%
₹2 Cr
▲100.0%
₹1 Cr
▼94.1%
₹17 Cr
▲183.3%
₹6 Cr
₹0 Cr
₹0 Cr
Net Cash Flow
₹-9 Cr
▼800.0%
₹-1 Cr
▼110.0%
₹10 Cr
▲600.0%
₹-2 Cr
▼120.0%
₹10 Cr
▲300.0%
₹-5 Cr
▼266.7%
₹3 Cr
▲50.0%
₹2 Cr
₹0 Cr
▲100.0%
₹-2 Cr
Free Cash Flow
₹-29 Cr
▼262.5%
₹-8 Cr
▼700.0%
₹-1 Cr
▲50.0%
₹-2 Cr
▼122.2%
₹9 Cr
▲250.0%
₹-6 Cr
▲68.4%
₹-19 Cr
▼850.0%
₹-2 Cr
₹0 Cr
▲100.0%
₹-26 Cr

Values in ₹ Cr · Source: Screener.in

Key Ratios History

MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Debtor Days
156d
▲4.7%
149d
▲4.9%
142d
▲7.6%
132d
▲8.2%
122d
▲11.9%
109d
▲26.7%
86d
▼41.9%
148d
▼24.5%
196d
▼31.5%
286d
Inventory Days
53d
▲194.4%
18d
▲80.0%
10d
▼64.3%
28d
▼20.0%
35d
▼50.0%
70d
▲94.4%
36d
▼7.7%
39d
▼53.6%
84d
▼23.6%
110d
Days Payable
189d
▲60.2%
118d
▼41.0%
200d
▼16.3%
239d
▼54.5%
525d
▲489.9%
89d
▲169.7%
33d
▼69.4%
108d
▼41.3%
184d
▲19.5%
154d
Cash Conv. Cycle
20d
▼60.0%
50d
▲204.2%
-48d
▲39.2%
-79d
▲78.5%
-367d
▼512.4%
89d
▲0.0%
89d
▲12.7%
79d
▼17.7%
96d
▼60.2%
241d
Working Capital Days
56d
▲86.7%
30d
▲850.0%
-4d
▲90.0%
-40d
▲82.1%
-223d
▼1113.6%
22d
▼40.5%
37d
▼60.2%
93d
▼19.1%
115d
▼50.9%
234d
ROCE
16.0%
▲23.1%
13.0%
▲30.0%
10.0%
▲66.7%
6.0%
▲100.0%
3.0%
▲200.0%
1.0%
▼83.3%
6.0%
▲20.0%
5.0%
▲155.6%
-9.0%
▲10.0%
-10.0%

Source: Screener.in · Lower days = better efficiency

About Kilitch Drugs (India) Limited

Incorporated in 1978, Kilitch Drugs Ltd is engaged in the operation and management of Pharmaceutical Products[1]

Healthcare · Pharmaceuticals & Biotechnology

Related Analysis

Same Sector

ALKEM
Alkem Laboratories Limited
Neutral
APOLLOHOSP
Apollo Hospitals Enterprise Limited
Neutral
AUROPHARMA
Aurobindo Pharma Limited
Neutral
BIOCON
Biocon Limited
Neutral
CIPLA
Cipla Limited
Neutral

Frequently Asked Questions

What is Kilitch Drugs (India) Limited share price today?▾
Kilitch Drugs (India) Limited (KILITCH) is currently trading at ₹173.7 on NSE, down 2.33% as of the last market session. Prices update daily after market close on MarketNetra.
Is Kilitch Drugs (India) Limited available in F&O (Futures & Options)?▾
Yes, Kilitch Drugs (India) Limited (KILITCH) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Kilitch Drugs (India) Limited 52-week high and low?▾
Kilitch Drugs (India) Limited's 52-week high is ₹250 and the 52-week low is ₹117. The current price of ₹173.7 is 30.5% below the 52W high.
What is Kilitch Drugs (India) Limited P/E ratio?▾
Kilitch Drugs (India) Limited's current P/E ratio is 20.7. This indicates the market is paying ₹20.7 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Kilitch Drugs (India) Limited options?▾
Kilitch Drugs (India) Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade KILITCH options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.